HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
HUMAN C1-ESTERASE INHIBITOR · KIT · CSL Behring GmbH
No Recall History
Plain English
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is a kit containing human c1-esterase inhibitor. Manufactured by CSL Behring GmbH.
Key Facts
- Brand Name
- HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
- Generic Name
- HUMAN C1-ESTERASE INHIBITOR
- NDC Code (Product)
63833-828- Manufacturer
- CSL Behring GmbH
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125606
- Marketing Start
- 06/22/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) used for?
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) contains HUMAN C1-ESTERASE INHIBITOR. It is a kit taken as directed. Consult your doctor for specific uses.
Is HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) a controlled substance?
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is not classified as a controlled substance by the DEA.
What is the generic name for HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)?
The generic name for HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is HUMAN C1-ESTERASE INHIBITOR. There are 3 other brand versions of HUMAN C1-ESTERASE INHIBITOR.
What is the NDC code for HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) ?
The NDC (National Drug Code) for HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) is 63833-828, listed by CSL Behring GmbH.